-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Carlsmed, Maintains $23 Price Target

Benzinga·09/28/2026 13:33:37
Listen to the news
BTIG analyst Ryan Zimmerman reiterates Carlsmed (NASDAQ:CARL) with a Buy and maintains $23 price target.